MTOR and acute lymphoblastic leukemia: Table 1 reports a summary of the main mTOR inhibitors in T-ALL models. However, there are still few data concerning the efficacy of this class of inhibitors for T-ALL, while some Phase I clinical studies conducted mostly on solid tumours have been released [118].